You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV-2,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

Recruiting
  • SARS-CoV2 Infection
  • General SARS-CoV-2 Communication
  • Rural-Targeted SARS-CoV-2 Communication
  • Flint, Michigan
    Flint Journal Building
Oct 10, 2023

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA Vaccine
  • Saline
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

Not yet recruiting
  • SARS-CoV-2
  • +4 more
  • LumiraDx SARS-CoV-2 Ag Ultra
  • LumiraDx SARS-CoV-2 & Flu A/B
  • DeLand, Florida
    Hillcrest Medical Research
Feb 6, 2023

COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

Not yet recruiting
  • COVID-19
  • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
  • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
  • (no location specified)
Aug 4, 2023

SARS-CoV-2 Vaccination on Cancer Patients Infected With

Recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine
  • no intervention
  • Beijing, Beijing, China
    Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023

SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
  • 0.9% sodium chloride solution
  • Islamabad, Pakistan
    Sindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

Not yet recruiting
  • SARS-CoV-2 Infection
  • +2 more
  • eBAM Cov Testing
  • Marseille, France
  • +1 more
Oct 23, 2023

Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

Not yet recruiting
  • Influenza A
  • +3 more
  • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
  • Raleigh, North Carolina
    Wake Med
Jun 26, 2023

Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test

Not yet recruiting
  • SARS-CoV-2
  • +3 more
  • LumiraDx SARS-CoV-2 & Flu A/B
  • Cullman, Alabama
    Cullman Clinical Trials
Mar 16, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

    Not yet recruiting
    • Respiratory Viral Infection
    • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
    • BioFire Respiratory Panel 2.1
    • (no location specified)
    Jul 13, 2023

    Coronavirus Trial in Oxford (SARS-CoV-2 virus)

    Recruiting
    • Coronavirus
    • SARS-CoV-2 virus
    • Oxford, Oxon, United Kingdom
    • +2 more
    Jan 5, 2023

    Sars-cov-2 on Donor Oocyte Quality and Quantity,Multicenter

    Completed
    • Ovarian Reserve
    • +2 more
    • Sars Cov 2 infection
    • Sars Cov 2 vaccination
    • Bogotá, Colombia
      Novafem
    Oct 3, 2022

    SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)

    Active, not recruiting
    • SARS-CoV-2
    • RBMRNA-176
    • Placebo
    • Chengdu, Sichuan, China
      Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
    Jun 12, 2023

    Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

    Active, not recruiting
    • SARS-CoV-2 RNA Vaccines
    • HIV Infection
    • SARS-CoV-2 Vaccine
    • Sevilla, Spain
      Virgen del Rocio University Hospital
    Dec 1, 2022

    Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)

    Active, not recruiting
    • Sars-CoV-2 Infection
    • Nasal and mouth swab
    • Negrar, Verona, Italy
      IRCCS Sacro Cuore Don Calabria hospital
    Mar 14, 2023

    SARS-CoV-2, Prevention Trial in Chongqing (MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray, Placebo Comparator: MY-586

    Recruiting
    • SARS-CoV-2
    • Prevention
    • MY-586 SARS-CoV-2 Neutralizing Antibody nasal spray
    • Placebo Comparator: MY-586 SARS-CoV-2 Neutralization Antibody nasal excipient
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 2, 2023

    COVID-19 Trial in Wong Chuk Hang (SARS-CoV-2 DNA Vaccine (ICCOV))

    Recruiting
    • COVID-19
    • SARS-CoV-2 DNA Vaccine (ICCOV)
    • Wong Chuk Hang, Hong Kong
      Gleneagles Hospital Hong Kong
    Jun 16, 2023

    SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 variant mRNA vaccine low dose
    • SARS-CoV-2 variant mRNA vaccine high dose
    • (no location specified)
    Oct 30, 2022